DK174624B1 - Sprøjteklare, vandige, alkaliske injektionsopløsninger af torasemid og fremgangsmåde til fremstilling deraf - Google Patents

Sprøjteklare, vandige, alkaliske injektionsopløsninger af torasemid og fremgangsmåde til fremstilling deraf Download PDF

Info

Publication number
DK174624B1
DK174624B1 DK198703602A DK360287A DK174624B1 DK 174624 B1 DK174624 B1 DK 174624B1 DK 198703602 A DK198703602 A DK 198703602A DK 360287 A DK360287 A DK 360287A DK 174624 B1 DK174624 B1 DK 174624B1
Authority
DK
Denmark
Prior art keywords
torasemide
solution
injection
buffer
organic solvent
Prior art date
Application number
DK198703602A
Other languages
Danish (da)
English (en)
Other versions
DK360287A (da
DK360287D0 (da
Inventor
Fritz Demmer
Werner Gruber
Heinrich Woog
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of DK360287D0 publication Critical patent/DK360287D0/da
Publication of DK360287A publication Critical patent/DK360287A/da
Application granted granted Critical
Publication of DK174624B1 publication Critical patent/DK174624B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Ink Jet (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pyridine Compounds (AREA)
DK198703602A 1986-07-12 1987-07-10 Sprøjteklare, vandige, alkaliske injektionsopløsninger af torasemid og fremgangsmåde til fremstilling deraf DK174624B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3623620 1986-07-12
DE19863623620 DE3623620A1 (de) 1986-07-12 1986-07-12 Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung

Publications (3)

Publication Number Publication Date
DK360287D0 DK360287D0 (da) 1987-07-10
DK360287A DK360287A (da) 1988-01-13
DK174624B1 true DK174624B1 (da) 2003-07-28

Family

ID=6305087

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198703602A DK174624B1 (da) 1986-07-12 1987-07-10 Sprøjteklare, vandige, alkaliske injektionsopløsninger af torasemid og fremgangsmåde til fremstilling deraf

Country Status (13)

Country Link
US (1) US4861786A (fi)
EP (1) EP0253226B1 (fi)
JP (1) JPS6323818A (fi)
KR (1) KR950010158B1 (fi)
AT (1) ATE53296T1 (fi)
AU (1) AU578562B2 (fi)
CA (1) CA1302278C (fi)
DE (2) DE3623620A1 (fi)
DK (1) DK174624B1 (fi)
ES (1) ES2016306B3 (fi)
FI (1) FI87993C (fi)
GR (1) GR3000534T3 (fi)
NZ (1) NZ221026A (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486530A (en) * 1991-04-27 1996-01-23 Boehringer Mannheim Gmbh Use of torasemide for the treatment of brain oedemas
DE4126984A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, gut vertraeglichen arzneimitteln fuer infusions- oder injektionszwecke
JP3028171B2 (ja) * 1993-08-31 2000-04-04 日本ピラー工業株式会社 複合ガスケット
US6228873B1 (en) 1994-12-09 2001-05-08 The Regents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
US5763491A (en) * 1994-12-09 1998-06-09 The Regents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
US5585401A (en) * 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
AU781461C (en) 1999-08-11 2006-02-23 Teva Pharmaceutical Industries Ltd. Torsemide polymorphs
AU2001247592B2 (en) 2000-03-20 2005-08-18 Teva Pharmaceutical Industries Ltd. Novel processes for preparing torsemide intermediate
EP1465596A1 (en) * 2002-01-18 2004-10-13 Control Delivery Systems, Inc. Polymeric gel system for the controlled delivery of codrugs
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
CN100372534C (zh) * 2006-04-20 2008-03-05 南京海辰药业有限公司 托拉塞米冻干制剂及制备方法
US20100053852A1 (en) * 2008-09-02 2010-03-04 Cheng Uei Precision Industry Co., Ltd. Display Device
CN103371967A (zh) * 2012-04-17 2013-10-30 上海禾丰制药有限公司 呋塞米注射液及其制剂工艺
JP6415535B2 (ja) * 2013-04-05 2018-10-31 エスシーファーマシューティカルズ インコーポレイテッド フロセミドの皮下投与用の医薬製剤
FR3077984B1 (fr) * 2018-02-16 2020-02-21 Vetoquinol Sa Composition multiusage de torasemide
CA3128033A1 (en) 2019-01-31 2020-08-06 Scpharmaceuticals Inc. Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same
CN110606826B (zh) * 2019-05-23 2021-06-01 上海勋和医药科技有限公司 托拉塞米钠一水合物、其晶型及组合物
CN112168776B (zh) * 2020-10-30 2022-05-03 康普药业股份有限公司 一种低杂质高稳定的托拉塞米注射液和制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE185374C (fi) *
DE30681C (de) * R.W. traylor in Richmond, County of Henrico State of Virginia, V. St. A Gufsform aus Glimmer
DK138974B (da) * 1974-02-19 1978-11-27 Ciba Geigy Ag Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
DE2950832C2 (de) * 1979-12-18 1983-03-17 Hoechst Ag, 6000 Frankfurt Spritzfertige injizierbare wäßrige Lösungen der Alkalisalze von Canrenoinsäure und Furosemid
DE3241765A1 (de) * 1982-11-11 1984-05-17 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin Stabile zubereitungen fuer injektionszwecke enthaltend hydrochlorothiazid
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
DE3529529A1 (de) * 1985-08-17 1987-02-19 Boehringer Mannheim Gmbh Verfahren zur herstellung einer stabilen modifikation von torasemid

Also Published As

Publication number Publication date
AU7535587A (en) 1988-01-14
GR3000534T3 (en) 1991-07-31
JPS6323818A (ja) 1988-02-01
DE3623620A1 (de) 1988-01-21
DK360287A (da) 1988-01-13
FI87993C (fi) 1993-03-25
EP0253226B1 (de) 1990-06-06
DE3763010D1 (de) 1990-07-12
KR880001294A (ko) 1988-04-22
AU578562B2 (en) 1988-10-27
JPH055810B2 (fi) 1993-01-25
EP0253226A1 (de) 1988-01-20
DE3623620C2 (fi) 1991-02-28
KR950010158B1 (ko) 1995-09-11
CA1302278C (en) 1992-06-02
ATE53296T1 (de) 1990-06-15
US4861786A (en) 1989-08-29
DK360287D0 (da) 1987-07-10
FI87993B (fi) 1992-12-15
NZ221026A (en) 1989-09-27
FI873059A (fi) 1988-01-13
FI873059A0 (fi) 1987-07-10
ES2016306B3 (es) 1990-11-01

Similar Documents

Publication Publication Date Title
DK174624B1 (da) Sprøjteklare, vandige, alkaliske injektionsopløsninger af torasemid og fremgangsmåde til fremstilling deraf
EP1465688B2 (en) Bicarbonate-based solutions for dialysis therapies
US5589491A (en) Injection and injection kit containing omeprazole and its analogs
KR960005705B1 (ko) 플로르페니콜의 약제학적 조성물
UA72268C2 (uk) Водна композиція моксифлоксацину, що містить хлорид натрію
EP1154770B1 (en) Parenteral formulation of piperacillin
CA2290461A1 (en) Antiseptic composition
EP0139534A2 (en) Compositions for the prophylactic treatment of osteitis and osteomyelitis
US6211185B1 (en) Concentrate comprising a sulfonamide in solution, a 2,4-diaminopyrimidine in stable suspension within said solution, and a suspending agent
JPH04275222A (ja) 安定性を強化したピロキシカム溶液、およびその製造方法
JPH07502544A (ja) 眼内組織潅注用および眼内外科処置中の瞳孔散大維持用組成物
US5633240A (en) Parenteral solutions containing metolazone
JP3954115B2 (ja) 注射剤および注射剤キット
JP3720262B2 (ja) 安定化したカルベジロール注射溶液
IE840047L (en) 1,3,5-triazin-2,4,6-trione agent for coccidiosis
US4423043A (en) Aqueous liquid formulations for control of bacterial and protozoal diseases
US3856964A (en) Concentrate for infusion purposes containing 5,5-diphenylhydantoin sodium
JPH0283318A (ja) 安定な点眼剤
SK3322003A3 (en) Infusion of ciprofloxacin having reduced acid content and being stable in storage
CA1154676A (en) Ready for use, injectable, aqueous solutions of alkali metal salts of canrenoic acid and furosemide and process for their preparation
EP0029668A1 (en) Pharmaceutical injectable composition and two-pack container for said composition
US4988722A (en) Parenteral compositions
US5684009A (en) Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides
JP3242924B2 (ja) 調製済みのアゾセミド(azosemide)注射液
US4742082A (en) Solution of luprostiol and 1,2,-propanediol and methods of preparation and use

Legal Events

Date Code Title Description
PUP Patent expired